SOMATULINE AUTOGEL 120mg injection solution in pre-filled syringe medication leaflet

H01CB03 lanreotide • Systemic hormonal preparations, excluding sex hormones and insulins | Hypothalamic hormones | Somatostatin and analogues

Lanreotide is a somatostatin analog used to treat acromegaly and certain neuroendocrine tumors. It works by inhibiting the secretion of hormones such as growth hormone and reducing blood flow to neuroendocrine tumors.

The medication is administered as subcutaneous injections, usually once every 4 weeks, as directed by a doctor. The treatment is effective in controlling symptoms and slowing disease progression.

Side effects may include pain at the injection site, nausea, diarrhea, or fatigue. In rare cases, severe allergic reactions or gallstone formation may occur.

Patients should strictly follow their doctor's instructions and inform them about any other medications they are taking. Pregnant or breastfeeding women should consult a specialist before use.

General data about SOMATULINE AUTOGEL 120mg

Substance: lanreotide

Date of last drug list: 01-06-2025

Commercial code: W58628001

Concentration: 120mg

Pharmaceutical form: injection solution in pre-filled syringe

Packing volume: 0,5 ml

Product type: original

Price: 2625.24 RON

Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).

Marketing authorisation

Manufacturer: IPSEN PHARMA BIOTECH-SIGNES - FRANTA

Holder: IPSEN PHARMA - FRANTA

Number: 4589/2012/01

Shelf life: 2 years-after packing for marketing;after openinga foliei laminate-it is used immediately

Concentrations available for lanreotide

120mg, 30mg, 60mg, 90mg

Other substances similar to lanreotide

Compensation lists for SOMATULINE AUTOGEL 120mg IPSEN

G22 (C1) - Endocrine diseases

Price

Copayment

Patient

2625.24 RON

2625.24 RON

0.00 RON

GX (C1) - GENERIC (used in compensation list, C1, for another diagnosis)

Price

Copayment

Patient

2625.24 RON

2625.24 RON

0.00 RON